Profitelligence Profitelligence · Filing Ledger Open DXCM research →

Form 8-K · Current Report · Filed 2025-05-13

DexCom Promotes Jake Leach to President and COO

DexCom, Inc. announced on May 9, 2025, the promotion of Jake Leach to President and Chief Operating Officer (COO) effective immediately. Leach, who has over 21 years of experience with the company, previously served as COO since 2022. His new role as President includes oversight of corporate development and strategy in addition to his existing COO responsibilities. The promotion is effective immediately, and Leach will report to Kevin Sayer, the current CEO and Chairman of the Board.

Filer
Dexcom Inc. DXCM · NASDAQ
Filed
Accession
0001093557-25-000159
CIK
0001093557
Signal
Medium impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

New President Appointed New COO Appointed
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$85.05

Next session

+1.7%

Since filing

-1.9%

Latest close

$83.45

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from DXCM reporting the same item, with the next session's move:

Exhibits (1)

About Dexcom Inc.

Dexcom Inc. is a prominent player in the medical technology sector, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company's primary function is to develop and distribute innovative CGM devices that provide real-time glucose readings, allowing individuals with diabetes to make informed decisions about their health. Dexcom’s products play a critical role in healthcare by offering an alternative to traditional fingerstick testing, thus improving quality of life for many users. The company impacts several sectors, most notably within healthcare and technology, by integrating advanced data analytics and wireless technology into its monitoring systems. This not only aids individuals in managing their glucose levels but also supports healthcare providers in delivering better patient care through data-driven insights. In the financial market, Dexcom Inc. is recognized for its contributions to the growing field of digital health solutions. The company has established itself as a leader in its niche, continuously pushing the boundaries of technology to offer more precise and user-friendly glucose monitoring options. Founded in 1999 and headquartered in San Diego, California, Dexcom remains at the forefront of diabetes management solutions.

Exchange NASDAQ Industry Medical Devices Company website ↗

Never miss another DXCM filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts